Jared Weiss, MDEnriched profile
Section Chief of Thoracic and Head/Neck Oncology; Professor of Medicine · University of North Carolina at Chapel Hill / UNC Lineberger Comprehensive Cancer Center
Overview
Updated 14 Jul 2026
Jared Weiss, MD, is Section Chief of Thoracic and Head/Neck Oncology at University of North Carolina at Chapel Hill / UNC Lineberger Comprehensive Cancer Center. The public record shows 96 publications with 6,955 citations (h-index 32), centered on Gastroesophageal Cancer, Lung Cancer (NSCLC/SCLC), Head & Neck Cancer. It also documents an investigator role on 17 registered clinical trials, industry payments reported by 29 companies, 1 NIH-funded awards (2025–2026).
- Top research focus: Gastroesophageal Cancer
- 17 registered trials on ClinicalTrials.gov
- Open Payments reporting from 29 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 17 registered studies on ClinicalTrials.gov. The most recent:
- Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
Sponsor: UNC Lineberger Comprehensive Cancer Center
InvestigatorPhase 1RecruitingNCT06096038 - Abequolixron (RGX-104) and Durvalumab in Lung Cancer
Sponsor: UNC Lineberger Comprehensive Cancer Center
InvestigatorPhase 1TerminatedNCT05911308 - Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
Sponsor: UNC Lineberger Comprehensive Cancer Center
InvestigatorEarly phase 1RecruitingNCT05620342
Industry payments
Updated 14 Jul 2026
29 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20257 payments
- Janssen Research & Development, LLCProgram year20251 payment
- Ipsen InnovationProgram year20251 payment
NIH funding
Updated 14 Jul 2026
1 NIH research award on record, funded 2025–2026 per NIH RePORTER. The latest:
- iC9-CAR.CSPG4 CAR-T Cells for Head and Neck Squamous Cell Carcinoma
Univ of North Carolina Chapel Hill
FY2026$627,456R01CA296807 - iC9-CAR.CSPG4 CAR-T Cells for Head and Neck Squamous Cell Carcinoma
Univ of North Carolina Chapel Hill
FY2025$627,456R01CA296807
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
170 Manning Drive, Room 3115, Chapel Hill, NC 27599
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rmei.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.unc.edu ↗
- MD
Yale University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - BS
Neuroscience, Brown University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Internal Medicine Residency
Beth Israel Deaconess Medical Center, Harvard
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Editorial & leadership rolesjournal and society appointments
- Section Chief
Thoracic and Head/Neck Oncology, UNC School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗ - Member
Cancer Therapeutics Research Program, UNC Lineberger
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗ - Member
Thoracic Oncology Program, UNC Lineberger
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →livelung.org ↗
- Regular contributing author/video commentator
OncLive (oncology news/education outlet)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗ - Contributing author
Targeted Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →targetedonc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Van Cutsem, MD, PhD
Universitair Ziekenhuis Leuven
- 1,845
- publications
- 177
- h-index
- 14
- trials
Josep Tabernero, MD, PhD
Vall d'Hebron Institut de Recerca
- 2,704
- publications
- 148
- h-index
- 19
- trials
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
- 1,745
- publications
- 154
- h-index
- 22
- trials
Charles Fuchs, MD, MPH
Yale Cancer Center
- 1,721
- publications
- 172
- h-index
- 7
- trials